Phase 2 Liver Cancer Trial, Recruiting NCT06205472 Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Condition: Liver Cancer
Back to Liver Cancer

Phase 2 Liver Cancer Trial, Recruiting

NCT06205472
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with hepatocellular carcinoma (liver cancer) through laboratory testing of tissue removed during surgery, where the surgical margin (the border between the tumour and the healthy tissue removed around it) was less than 1 centimetre wide
  • People who are older than 18 years of age
  • People who have recovered from their surgery and are able to carry out normal daily activities with little or no limitation (as measured by a standard medical scoring tool)
  • People whose liver function falls within a specific healthy range, as measured by a standard scoring system called the Child-Pugh score (A5 or A6) (confirm with trial site)
  • People with an estimated life expectancy of more than 3 months
  • People whose cancer has not spread to distant parts of the body
  • People whose blood test results meet specific minimum levels for red blood cells, white blood cells, and platelets
  • People whose liver enzyme levels (ALT and AST) are within acceptable ranges based on standard reference values
  • People whose kidney function markers (creatinine and blood urea nitrogen) are within acceptable ranges based on standard reference values
  • People who are willing to participate and have signed an informed consent form

Who may not be able to join:

  • People who have a history of other cancers, except for a type of skin cancer called basal cell carcinoma or early-stage cervical cancer confined to its original location
  • People who have previously had radiation therapy to the abdomen
  • People who have previously had a liver transplant
  • People who have serious heart muscle disease or kidney failure
  • People who have a moderate or severe build-up of fluid in the abdomen causing noticeable symptoms
  • People where more than 3 months have passed since their surgery

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 00861324000876

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Registry
ClinicalTrials.gov
Start date
26 January 2024
Est. completion
12 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The 3-year Overall Survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov